| HOME >> BIOLOGY >> TECHNOLOGY |
Dallas, Texas (PRWEB) January 07, 2013
Biologic imaging reagents play an important role in the medical, pharmaceutical, diagnostic, biotechnology and life sciences tools industries. Imaging and detection technologies are used extensively in medicine, biotechnology and pharmaceutical research. Traditional imaging techniques, such as X-ray, computer tomography (CT), ultrasound (US), magnetic resonance imaging (MRI) and nuclear medicine (NM), mainly analyze anatomy and morphology and cannot detect changes at the molecular level. However, new developments in biotechnology permits imaging at the cellular and molecular level, paving the way for earlier diagnosis and treatment of diseases. Biologic imaging reagents play a critical role in this medical revolution.
At the same time, ongoing advances in genomics, proteomics and cellular analysis are aided by imaging technologies, including fluorescent dyes and probes, quantum dot nanoparticles, and fluorescent proteins. Growth in technologies such as biochips, DNA sequencing and polymerase chain reaction (PCR) relies on sensitive biologic fluorescent imaging reagents.
Advances in technologies that are used in biologic imaging reagents are also moving forward at a rapid pace. These technologies include nanotechnology, biologic targeting, microfluidics, supramolecular chemistry and protein engineering. Rapid developments across a number of technology fields promise to change the biologic imaging industry by enabling novel imaging reagents and unique market opportunities. The report “Biologic Imaging Reagents: Technologies and Global Markets” analyzes these developments and their impact on the future markets for biologic imaging reagents.
Given these market and technology dynamics, it is especially timely to examine t
'/>"/>
| Source: PRWeb Copyright©2012 Vocus, Inc. All rights reserved |